Trial Profile
A Phase I Trial of Combined Nimotuzumab With NK Cells Adoptive Transfer for the Treatment of Advanced Cancer
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Natural killer cell therapy (Primary) ; Nimotuzumab (Primary) ; Hydrocortisone
- Indications Cancer
- Focus Adverse reactions
- 19 Jun 2018 New trial record